Macomics secures investment to develop cancer therapies

New start up launches with a £3.2 million seed funding.

Image
Doctor Cassetta Macomics
Macomics co-founder, Dr Luca Cassetta.
Macomics is leading academic research around macrophage biology, particularly in cancer.

Developed by Professor Jeffrey Pollard, Director of the MRC Centre for Reproductive Health at the University of Edinburgh, working with co-founder Dr Luca Cassetta.

Read about their success.